Literature DB >> 17693486

Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family.

Csilla Csortos1, Irina Kolosova, Alexander D Verin.   

Abstract

Reversible phosphorylation of cytoskeletal and cytoskeleton-associated proteins is a significant element of endothelial barrier function regulation. Therefore, understanding the mechanisms of phosphorylation/dephosphorylation of endothelial cell cytoskeletal proteins is vital to the treatment of severe lung disorders such as high permeability pulmonary edema. In vivo, there is a controlled balance between the activities of protein kinases and phosphatases. Due to various external or internal signals, this balance may be shifted. The actual balances at a given time alter the phosphorylation level of certain proteins with appropriate physiological consequences. The latest information about the structure and regulation of different types of Ser/Thr protein phosphatases participating in the regulation of endothelial cytoskeletal organization and barrier function will be reviewed here.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693486     DOI: 10.1152/ajplung.00120.2007

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  22 in total

Review 1.  The role of cytoskeleton in the regulation of vascular endothelial barrier function.

Authors:  Natalia V Bogatcheva; Alexander D Verin
Journal:  Microvasc Res       Date:  2008-06-28       Impact factor: 3.514

2.  TIMAP is a positive regulator of pulmonary endothelial barrier function.

Authors:  Csilla Csortos; Istvan Czikora; Natalia V Bogatcheva; Djanybek M Adyshev; Christophe Poirier; Gabor Olah; Alexander D Verin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-27       Impact factor: 5.464

3.  Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense.

Authors:  Sascha David; Chandra C Ghosh; Aditi Mukherjee; Samir M Parikh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

4.  Molecular characterization of myosin phosphatase in endothelium.

Authors:  Kyung-Mi Kim; Csilla Csortos; Istvan Czikora; David Fulton; Nagavedi S Umapathy; Gabor Olah; Alexander D Verin
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

Review 5.  Regulation of pulmonary endothelial barrier function by kinases.

Authors:  Nektarios Barabutis; Alexander Verin; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

6.  Role of calcineurin in thrombin-mediated endothelial cell contraction.

Authors:  Bernadett Kolozsvári; Zsolt Szíjgyártó; Péter Bai; Pál Gergely; Alexander Verin; Joe G N Garcia; Eva Bakó
Journal:  Cytometry A       Date:  2009-05       Impact factor: 4.355

7.  Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening.

Authors:  Kyung-mi Kim; Djanybek M Adyshev; Anita Kása; Evgeny A Zemskov; Irina A Kolosova; Csilla Csortos; Alexander D Verin
Journal:  Microvasc Res       Date:  2013-04-12       Impact factor: 3.514

Review 8.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

9.  Critical role of PBEF expression in pulmonary cell inflammation and permeability.

Authors:  Peng Liu; Hailong Li; Javier Cepeda; Li Qin Zhang; Xiuyun Cui; Joe G N Garcia; Shui Qing Ye
Journal:  Cell Biol Int       Date:  2008-11-01       Impact factor: 3.612

10.  Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Authors:  Joyce N Gonzales; Kyung-mi Kim; Marina A Zemskova; Ruslan Rafikov; Brenten Heeke; Matthew N Varn; Stephen Black; Thomas P Kennedy; Alexander D Verin; Evgeny A Zemskov
Journal:  Vascul Pharmacol       Date:  2014-01-25       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.